CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
59.72
0.90 (1.53%)
At close: Aug 15, 2025, 3:59 PM
59.96
0.40%
After-hours: Aug 15, 2025, 07:57 PM EDT
CRISPR Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -467.8M | -385.66M | -366.25M | -239.59M | -265.8M | -217.14M | -153.61M | -353.53M | -415.93M | -524.02M | -650.17M | -680.85M | -633.45M | 311.61M | 377.66M | 411.87M | 446.58M | -392.3M |
Depreciation & Amortization | 18.97M | 19.16M | 19.26M | 19.32M | 19.5M | 19.62M | 19.84M | 20.78M | 20.88M | 23.18M | 24.17M | 24.59M | 24.89M | 21.28M | 17.95M | 14.26M | 11.27M | 9.81M |
Stock-Based Compensation | 81.31M | 87.37M | 86.57M | 83.04M | 81.47M | 79.56M | 81.03M | 85.41M | 89.99M | 93.08M | 97.95M | 100.91M | 102.56M | 106.04M | 102.39M | 95.55M | 86.59M | 73.96M |
Other Working Capital | -1.55M | 29.5M | 703K | -3.92M | -19.16M | -29.45M | -18.8M | -43.36M | 11.25M | 20.14M | 14.38M | 32.73M | 4.86M | 18.5M | 12.8M | 24.52M | 12.37M | 6.33M |
Other Non-Cash Items | 107.46M | -3.9M | -194.91M | -184.52M | -182.78M | -201.83M | -14.04M | -9.06M | -1.32M | 5.4M | 12.47M | 16.94M | 19.36M | 18.14M | 14.11M | 10.3M | 5.38M | 3.03M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -64.71M | 628K | 156.27M | -23.35M | 69.57M | -20M | -193.59M | -21.23M | -36.61M | 50.66M | 19.84M | 69.96M | 42.07M | 47.33M | 26.86M | 11.82M | -404K | 18.64M |
Operating Cash Flow | -324.77M | -306.47M | -142.77M | -188.82M | -121.76M | -159.42M | -260.38M | -277.63M | -342.99M | -351.7M | -495.74M | -468.45M | -444.56M | 504.4M | 538.97M | 543.8M | 549.43M | -286.85M |
Capital Expenditures | -796K | -1.39M | -1.9M | -2.38M | -4.28M | -7.13M | -9.47M | -14.92M | -18.82M | -24.9M | -37.19M | -40.18M | -71.21M | -90.03M | -81.7M | -78.76M | -47.23M | -22.39M |
Cash Acquisitions | n/a | n/a | n/a | 80.72M | 80.72M | 80.72M | -40.17M | 48.45M | -45.03M | 1.41M | 122.3M | -47.04M | 46.44M | n/a | n/a | -324.81M | -324.81M | -324.81M |
Purchase of Investments | -1.07B | -1.34B | -1.47B | -1.57B | -1.42B | -1.13B | -1.07B | -1.19B | -1.27B | -1.36B | -1.42B | -1.05B | -1.39B | -1.51B | -1.51B | -1.66B | -1.31B | -917.97M |
Sales Maturities Of Investments | 1.12B | 1.16B | 1.21B | 1.12B | 1.24B | 1.3B | 1.45B | 1.49B | 1.54B | 1.36B | 1.2B | 994.29M | 717.21M | 616.48M | 555.6M | 503.27M | 361.11M | 234.29M |
Other Investing Acitivies | -55.09M | -146.58M | -154.08M | -234.8M | -215.41M | -90.72M | 37.67M | -50.95M | 43.53M | -1.41M | -221.47M | -51.66M | -673.27M | -892.02M | -953.73M | -629.38M | -426.06M | -160.87M |
Investing Cash Flow | -5.55M | -202.44M | -280.48M | -467.76M | -184.81M | 159.02M | 374.65M | 280.57M | 246.68M | -26.31M | -258.65M | -91.84M | -744.48M | -982.05M | -1.04B | -1.23B | -996.11M | -706.08M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.77M | 21.17M | 21.17M | 21.17M | 17.88M |
Common Stock Repurchased | 71.25M | -466K | -466K | -466K | -466K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -52.85M | 7.63M | 30.74M | 35.04M | 32.96M | 49.73M | 29.94M | 26.2M | 38.79M | 32.38M | 37.62M | 41.44M | 37.51M | 25.84M | 15.19M | 21.45M | 24.92M | 26.25M |
Financial Cash Flow | 39.36M | 36.64M | 331.98M | 354.05M | 345.96M | 363.19M | 62.66M | 26.2M | 39.76M | 33.35M | 38.59M | 42.41M | 37.51M | 35.6M | 250.94M | 657.27M | 1.16B | 1.24B |
Net Cash Flow | -279.33M | -460.72M | -79.7M | -290.81M | 39.47M | 362.89M | 177.01M | 29.27M | -56.47M | -344.69M | -715.88M | -518.07M | -1.15B | -442.09M | -245.52M | -29.87M | 713.35M | 248.15M |
Free Cash Flow | -325.57M | -307.86M | -144.68M | -191.2M | -126.04M | -166.55M | -269.85M | -292.55M | -361.81M | -376.6M | -532.93M | -508.63M | -515.77M | 414.37M | 457.27M | 465.04M | 502.19M | -309.25M |